Ampio Pharmaceuticals, Inc. (AMPE)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 250 Thousand | 2.07 Million | 1.09 Million | 1.17 Million | 1.27 Million | 523 Thousand |
| Gross Profit | -250 Thousand | -2.07 Million | -1.09 Million | -1.17 Million | -1.27 Million | -523 Thousand |
| Operating Expenses | 9.26 Million | 20.38 Million | 20.57 Million | 15.83 Million | 18.57 Million | 11.18 Million |
| Selling, General and Administrative Expenses | 7.07 Million | 11.46 Million | 8.67 Million | 6.65 Million | 5.89 Million | 4.35 Million |
| Research and Development Expenses | 2.43 Million | 8.91 Million | 11.9 Million | 9.17 Million | 12.62 Million | 6.82 Million |
| Other Expenses | - | 1.93 Million | - | 12 Thousand | 56 Thousand | - |
| Cost and Expenses | 9.51 Million | 20.38 Million | 20.57 Million | 15.83 Million | 18.57 Million | 11.18 Million |
| Operating Income | -9.51 Million | -24.2 Million | -25.15 Million | -15.21 Million | -23.44 Million | -11.18 Million |
| Interest Expense | - | - | - | - | 77 Thousand | - |
| Income Tax Expense | - | -7.87 Million | -4.59 Million | 604 Thousand | -4.94 Million | 45.17 Million |
| Earnings before Tax | -8.63 Million | -16.33 Million | -17.07 Million | -15.89 Million | -13.63 Million | 33.98 Million |
| Net Income | -8.63 Million | -8.46 Million | -12.48 Million | -16.49 Million | -8.68 Million | 33.98 Million |
| Earnings Per Share Basic | -10.67 | -11.24 | -18.79 | -28.63 | -18.32 | 92.10 |
| Earnings Per Share Diluted | -10.66 | -11.24 | -18.59 | -27.71 | -18.32 | 91.90 |
| Weighted Average Shares Outstanding | 809 Thousand | 753.61 Thousand | 664.33 Thousand | 576.15 Thousand | 474.02 Thousand | 369 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 810.11 Thousand | 753.61 Thousand | 671.49 Thousand | 595.4 Thousand | 474.02 Thousand | 369.8 Thousand |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | - | -18.3 Million | - | - | -17.3 Million | 35.26 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Revenue | - | 490 Thousand | - | - | - | - |
| Cost of Revenue | 250 Thousand | 245 Thousand | - | - | 245 Thousand | 2.07 Million |
| Gross Profit | -250 Thousand | 245 Thousand | - | - | -245 Thousand | -2.07 Million |
| Operating Expenses | 9.26 Million | 2.21 Million | 1.4 Million | 1.56 Million | 4.34 Million | 20.38 Million |
| Selling, General and Administrative Expenses | - | 973 Thousand | 1.07 Million | 1.21 Million | 3.81 Million | - |
| Research and Development Expenses | - | 1.24 Million | 329 Thousand | 344 Thousand | 524 Thousand | - |
| Other Expenses | 56 Thousand | 93 Thousand | 92 Thousand | 91 Thousand | 324 Thousand | 1.93 Million |
| Cost and Expenses | 9.51 Million | 2.21 Million | 1.4 Million | 1.56 Million | 4.34 Million | 20.38 Million |
| Operating Income | -9.51 Million | -2.21 Million | -1.22 Million | -1.37 Million | -4.28 Million | -24.2 Million |
| Interest Expense | - | 303 Thousand | - | - | -303 Thousand | -7.87 Million |
| Income Tax Expense | - | -43.81 Thousand | 92 Thousand | 91 Thousand | -303 Thousand | -7.87 Million |
| Earnings before Tax | -8.63 Million | -2.05 Million | -1.22 Million | -1.37 Million | -3.97 Million | -16.33 Million |
| Net Income | -8.63 Million | -2.05 Million | -1.22 Million | -1.37 Million | -3.67 Million | -8.46 Million |
| Earnings Per Share Basic | - | -2.48 | -1.53 | -1.82 | -4.87 | - |
| Earnings Per Share Diluted | - | -2.48 | -1.53 | -1.82 | -4.87 | - |
| Weighted Average Shares Outstanding | 810.11 Thousand | 829.79 Thousand | 804.15 Thousand | 754.69 Thousand | 754.69 Thousand | 753.61 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 810.11 Thousand | 829.79 Thousand | 804.15 Thousand | 754.69 Thousand | 754.69 Thousand | 753.61 Thousand |
| Gross Margin | - | 0.50 | - | - | - | - |
| EBIT Margin | - | -4.52 | - | - | - | - |
| Profit Margin | - | -4.19 | - | - | - | - |
| EBITDA | - | -2.21 Million | -1.4 Million | -1.56 Million | -4.15 Million | - |
| Earnings Before Tax Margin | - | -4.52 | - | - | - | - |
7388
COTY
4171
LTH
3946
FINGF